News

Victoria's Secret Reports Q4 Success Amidst Challenges Ahead

Victoria's Secret Reports Q4 Success Amidst Challenges Ahead

Victoria's Secret Announces Fourth Quarter Results

Victoria's Secret & Co. (NYSE: VSCO) has shared its fourth-quarter results, revealing an impressive revenue growth of 1% year over year, reaching $2.11 billion. This figure surpassed market expectations, which had consensus estimates at approximately $2.09 billion.

Strong Performance in Comparable Sales

The company reported a 5% increase in total comparable sales during the quarter. This surge was largely boosted by strong performances across both the Victoria’s Secret and PINK brands, as well as in the Beauty segment. Holiday sales proved beneficial for the company, affirming its ability to attract customers both in-store and through digital platforms.

Financial Highlights of the Quarter

In addition to the revenue success, Victoria's Secret saw a rise in adjusted operating income, climbing to $299 million compared to $283 million from the same period last year. Furthermore, the company made a significant accounting revision that resulted in a cumulative upward adjustment of net sales, gross margin, and operating income by approximately $26 million.

Exceeding Earnings Expectations

The adjusted earnings per share (EPS) stood at $2.60, which exceeded expectations that were set at $2.30. This was a notable improvement above the provided guidance which suggested an adjusted EPS range of $2.00 to $2.30. CEO Hillary Super expressed pride in the robust performance, stating, “Sales increased across most major merchandise categories, in our stores and digital channels, and in both our North America and International businesses. We won in the big moments of the quarter and gained more than our fair share of the traffic in the mall and online.”

Looking Ahead: Outlook for 2025

However, the company addressed forthcoming challenges. In her statements, Hillary Super mentioned, “As we look forward to 2025 and the future, we recognize there are near-term headwinds and ongoing uncertainty in the macro environment which we will manage aggressively while also working to build upon our solid foundation.” This dedication emphasizes that while the brand performs well, it is not without its challenges.

First Quarter Expectations

For the upcoming first quarter, Victoria’s Secret projects net sales between $1.30 billion and $1.33 billion, though this is below the market consensus expecting sales of $1.39 billion. The anticipated adjusted operating income for the forthcoming quarter is between $10 million and $30 million.

Full Year Projections for FY25

In terms of future expectations, Victoria's Secret forecasts full-year sales for FY25 to range from $6.2 billion to $6.3 billion, comparing unfavorably against the consensus of $6.34 billion. The company is also looking forward to adjusted operating income between $300 million and $350 million.

Current Market Performance

As for market performance, shares of VSCO experienced a decline of 5.45% and were recorded at $21.00 during premarket trading on the day of the announcement. This represents a significant shift and reflects investor caution in light of the near-term challenges highlighted by management.

Frequently Asked Questions

1. What were the key financial results for Victoria's Secret in Q4?

The company reported a revenue of $2.11 billion, with a 1% increase over the previous year.

2. How did the company's adjusted EPS perform?

The adjusted EPS was $2.60, surpassing consensus estimates of $2.30.

3. What challenges does Victoria's Secret anticipate for 2025?

The CEO noted near-term headwinds and uncertainty in the macro environment that they plan to manage aggressively.

4. What are the projected revenues for Victoria's Secret in FY25?

Victoria's Secret anticipates total net sales of approximately $6.2 billion to $6.3 billion for FY25.

5. How did the stock react to the fourth-quarter results?

Shares of VSCO fell by 5.45% during premarket trading following the announcement.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ACACIA's Big Move with Bel-Mac and Seashore: Will It Pay Off?

Updated Category News Views 19

A New Powerhouse in Roofing Services? Take a seat, folks—we're talking about a regional shakeup in the world of roofing and exterior building. ACACIA Exterior Building Group, based out of Alexandria, Virginia, just tightened its grip on the Mid-Atlantic and Gulf Coast markets by investing in Bel-Mac Roofing and Seashore Construction. This ain't just your run-of-the-mill...

Continue Reading
Historic Williamsburg Loft Gets a Modern Makeover

Updated Category News Views 46

Breathing New Life into a Brooklyn Classic Alright, picture this: You're stepping into a century-old Brooklyn loft, expecting dust, aged wood, maybe a ghost or two. What you actually find is art wrapped in brass with a splash of modern flair. This ain't just any loft, folks—it's the latest trophy on the mantle for Gallery KBNY, a design-build firm known for its...

Continue Reading
Lifeway Foods Set to Announce Q3 2026 Financial Results

Updated Category News Views 36

Anticipating Lifeway Foods’ Q3 Results Dust off your calendars and mark November 12, 2026—because that's when Lifeway Foods is putting its cards on the table for the third quarter. Nothing like a results call to see if your investments are eating right. NASDAQ:LWAY is no stranger to making some noise in the dairy aisle, thanks to their kefir—that fermented probiotic...

Continue Reading
BJ's Brews a New Dessert Innovation with Pizookie

Updated Category News Views 49

Banana Bread Meets Nutella in BJ's Latest Pizookie Right off the bat, let's cut to the heart of this dessert innovation. BJ's Restaurant & Brewhouse, traded under NASDAQ:BJRI, has fired up its dessert menu with something new: the Nutella® Gone Bananas Pizookie®. This isn't just another sweet treat—it’s a bold move, and if you're wondering why, you're in good...

Continue Reading
Bambusa Therapeutics: IPO Priced At $16, Shares On Nasdaq

Updated Category News Views 0

How Does Bambusa Therapeutics Stack Up? Well, here we go again in the biotech bonanza, folks. Bambusa Therapeutics is stepping onto the stage with their shiny new upsized IPO, offering a whopping 10,555,555 shares at sixteen bucks a pop. That's real money, coming in at $168,888,880 in gross proceeds if everything goes according to plan. Seems like a hefty sum, but in this...

Continue Reading
Bulletproof Gets Nod for AI Expertise, Eyes Future Growth

Updated Category News Views 70

Bulletproof's Recognition: A Sign of AI Prowess Let's dive right into today's news: Bulletproof just snagged a spot on the 2026 CRN AI Innovators list. Now, this is big leagues stuff, especially since this list highlights the top dogs in the AI space across North America. We're talking about managed service providers, value-added resellers, and all those tech wizards who...

Continue Reading
Ashling's New Feat: Microsoft Recognition in AI

Updated Category News Views 106

Microsoft's Stamp of Approval for Ashling Ah, recognition—it's not just for egos. When Ashling, an AI consultancy heavyweight, gets a nod from Microsoft, it's worth more than a footnote in the company newsletter. This isn't some participation trophy. Nope, it's a badge saying they know their Data & AI, and Digital & App Innovation inside out. On October 29, 2026,...

Continue Reading
Virax Biolabs Expands China Reach With Key Partnerships

Updated Category News Views 68

Virax Biolabs' Strategic Play in China Does Virax Biolabs have a trick up its sleeve, or is it just rolling the dice in the vast Chinese market? With three new distributor agreements, it sure seems like it's trying to tip the scales in its favor. The London-based company announced new distribution agreements for its ImmuneSelect research-use immune profiling products....

Continue Reading
Farrin Firm Stands Out Again in Triangle's Fast 50

Updated Category News Views 27

Law Offices of James Scott Farrin in the Spotlight Another triumph for the Law Offices of James Scott Farrin. Not a newbie to recognition, this marks the third time in a row they've landed on the 'Triangle Business Journal's' esteemed 'Fast 50' list. They're the sole law firm among the Triangle's 50 fastest-growing private companies, making waves in a sea usually...

Continue Reading
Torchy's Tacos Reintroduces Nookies: Fan Favorite Returns

Updated Category News Views 55

A Sweet Return to the Menu In the wild world of fast-casual dining, bringing back a beloved menu item is like striking gold. Torchy's Tacos is doing just that by reintroducing their legendary Nookies—fried chocolate chip cookie dough bites that have been a crowd favorite since 2008. After a two-year hiatus, these treats are back, complete with a cinnamon-sugar twist to...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Action Against Jetstar for Misleading Passenger Rights

Updated Category News Views 207

Legal Action Against Jetstar for Misleading Passenger Rights New Zealand's competition authority is taking serious action against Jetstar, a low-cost airline operating under Qantas. They're in court over allegations that Jetstar misled its passengers about their rights to compensation due to delayed and cancelled flights. Allegations of Misleading Practices The New...

Continue Reading
Loona Petbot Commemorates Anniversary with User Engagement Surge

Updated Category News Views 197

Loona Petbot Commemorates Anniversary with Impressive User Engagement KEYi Technology is excited to share the remarkable success of its 1000-day anniversary celebration of the Loona Petbot. This event commenced recently and received an overwhelming response from users around the world. More than ten thousand participants engaged in the celebrations, showcasing the growing...

Continue Reading
Exploring Royce Small-Cap Trust: Current Insights and Trends

Updated Category News Views 145

Introduction to Royce Small-Cap Trust Royce Small-Cap Trust (NYSE: RVT) stands as a prominent name in the small-cap investment landscape, renowned for its commitment to long-term capital growth. Established as one of the oldest and largest closed-end funds focused on small-cap and micro-cap securities, this trust has carved a niche for itself among investors seeking...

Continue Reading
Grace Hill Teams with IWBI to Advance WELL Workspaces

Updated Category News Views 8

Pushing the Boundaries of Building Health The workplace is evolving, pal, and it ain't the stodgy cubicle farm it once was. Grace Hill, the technological maestro of real estate performance solutions, has shaken hands with the International WELL Building Institute (IWBI). This move ain't just about pushing a few papers but about bringing the occupant experience front and...

Continue Reading
Oppenheimer Upholds Outperform Rating for Tarsus Pharmaceuticals

Updated Category News Views 63

Oppenheimer Reaffirms Positive Outlook on Tarsus Pharmaceuticals Recently, Oppenheimer reiterated its favorable stance on Tarsus Pharmaceuticals (NASDAQ:TARS), affirming an Outperform rating coupled with a price target of $63. This endorsement comes ahead of the company's anticipated financial report for the third quarter of 2024, with special attention on the performance...

Continue Reading